Exploring New Formulation Possibilities with Bile Salts
How can bile salts help overcome the challenges of poorly soluble compounds?
Poor aqueous solubility remains one of the key challenges in pharmaceutical development, often limiting the bioavailability of promising drug candidates and making formulation development increasingly complex.
To explore new approaches to this challenge, ICE Pharma and SeraNovo are joining forces for a technical webinar focused on the potential of bile salts as functional excipients in modern drug delivery platforms.
The session will examine how bile salts can support the formulation of difficult-to-formulate molecules and potentially open new opportunities for compounds with challenging solubility and bioavailability profiles.
What will we explore?
During the webinar, the discussion will focus on three key areas:
- Enhancing bioavailability: how bile salts can contribute to improving the bioavailability of poorly soluble compounds.
- Beyond traditional approaches: where bile salts may offer advantages compared with conventional amorphous solid dispersion strategies.
- New formulation opportunities: how bile salts could support the development of drug delivery platforms for challenging molecules in pharmaceutical pipelines.
Representing ICE Pharma, Madalina Cociorb, PhD, Business Development Manager, will join the SeraNovo team for a technical discussion exploring the role and potential of bile salts in formulation development.
Webinar details
Date: Tuesday, 29 September 2026
Sessions: 10:00 CEST and 17:00 CEST
Whether you are working with poorly soluble compounds or exploring new approaches to formulation development, the webinar will provide an opportunity to discover how excipient selection can play a role in unlocking new formulation possibilities.